one hundred sixty-two children with severe juvenile rheumatoid arthritis were entered in a randomized , double-blind , placebo-controlled 12-month clinical trial designed to establish the efficacy and safety of two slower-acting antirheumatic drugs , penicillamine and hydroxychloroquine .
C0003191
antirheumatic drugs
C0020336
hydroxychloroquine